The Washington Post, November 19, 2011. “The science is clear: Breast cancer patients are more likely to be harmed than helped by Avastin,” said Diana Zuckerman, president of the National Research Center for Women & Families. “The risks of the drug are very substantial and can be fatal, killing patients long before they would otherwise die from the disease. FDA made a scientific decision, and it was absolutely the right decision.”
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
FDA Revokes Approval of Avastin for Breast Cancer
Associated Press, November 18, 2011. Dr. Diana Zuckerman, tells AP about the problems with Avastin.
Read More »Lawmakers May Relax FDA Drug Conflict Rules
Reuters, November 1, 2011. Dr. Diana Zuckerman, president of the National Research Center for Women & Families, talks about the need for stronger conflict of interest rules for the FDA.
Read More »Birth-Control Pills Tied to Dangerous Clots: Which Brands?
CBS News, October 27, 2011. Dr. Diana Zuckerman, president of the National Research Center for Women & Families, questions why the FDA approves birth control pills that are less safe and have no benefit compared to drugs already on the market.
Read More »FDA says Yaz and Other Next-Generation Birth Control Drugs Appear to Increase Blood Clot Risk
The Republic, October 27, 2011. NRC President, Dr. Diana Zuckerman tells the Republic about problems with the popular birth control Yaz. She questions why you would take Yaz, the more expensive option that can potentially kill you.
Read More »